AfricaRegulatory
African Pharmaceutical Regulatory Intelligence
🇿🇦
Diphtheria Toxoid in South Africa
6 products registered with SAHPRA — 5 active
| Brand / Product | Reg. No. | Holder | Status | Expires |
|---|---|---|---|---|
| DIFTAVAX | 36/30.1/0128 | Sanofi-Aventis South Africa (Pty) Ltd | suspended | 3 Dec 2024 |
| HEXAXIM | 46/30.1/0447 | Sanofi-Aventis South Africa (Pty) Ltd | active | 1 Jan 1900 |
| BOOSTRIX TETRA | 43/30.2/0526 | GlaxoSmithKline South Africa (Pty) Limited | active | 1 Jan 1900 |
| ADACEL QUADRA | 42/30.1/0118 | Sanofi-Aventis South Africa (Pty) Ltd | active | 1 Jan 1900 |
| INFANRIX HEXA | 36/30.1/0347 | GlaxoSmithKline South Africa (Pty) Limited | active | 1 Jan 1900 |
| TETRAXIM | A38/30.1/0526 | Sanofi-Aventis South Africa (Pty) Ltd | active | 1 Jan 1900 |
Diphtheria Toxoid — SAHPRA Registration Details
SAHPRA (South Africa) has 6 registered products containing Diphtheria Toxoid, of which 5 are currently active. Data is sourced directly from the official SAHPRA drug register and refreshed daily.
Track Diphtheria Toxoid registration expiry dates, monitor competitor approvals, and receive alerts when registration status changes. Create a free account to set up portfolio monitoring.